UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey

Bone marrow transplantation (Basingstoke), 2016-06, Vol.51 (6), p.778-785

2016

Volltextzugriff (PDF)

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group

Leukemia, 2015-11, Vol.29 (11), p.2126-2133

2015

Volltextzugriff (PDF)

The challenge of biosimilars

Annals of oncology, 2008-03, Vol.19 (3), p.411-419

2008

Volltextzugriff (PDF)

Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

Bone marrow transplantation (Basingstoke), 2014-02, Vol.49 (2), p.168-173

2014

Volltextzugriff (PDF)

Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation

Leukemia, 2012-12, Vol.26 (12), p.2462-2468

2012

Volltextzugriff (PDF)

Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT

Bone marrow transplantation (Basingstoke), 2015-12, Vol.50 (12), p.1542-1550

2015

Volltextzugriff (PDF)

The EBMT activity survey 2009: trends over the past 5 years

Bone marrow transplantation (Basingstoke), 2011-04, Vol.46 (4), p.485-501

2011

Volltextzugriff (PDF)

NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia

Leukemia, 2015-03, Vol.29 (3), p.535-547

2015

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib

Bone marrow transplantation (Basingstoke), 2014-02, Vol.49 (2), p.179-184

2014

Volltextzugriff (PDF)

Alloreactivity: the Janus-face of hematopoietic stem cell transplantation

Leukemia, 2017-08, Vol.31 (8), p.1752-1759

2017

Volltextzugriff (PDF)

Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study

Haematologica (Roma), 2013-08, Vol.98 (8), p.1282-1290

2013

Volltextzugriff (PDF)

Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysis

Journal of internal medicine, 2019-04, Vol.285 (4), p.407-418

2019

Volltextzugriff (PDF)

Prediction of non-relapse mortality in recipients of reduced intensity conditioning allogeneic stem cell transplantation with AML in first complete remission

Leukemia, 2015-01, Vol.29 (1), p.51-57

2015

Volltextzugriff (PDF)

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009

Bone marrow transplantation (Basingstoke), 2010-02, Vol.45 (2), p.219-234

2010

Volltextzugriff (PDF)

Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT

Bone marrow transplantation (Basingstoke), 2016-03, Vol.51 (3), p.351-357

2016

Volltextzugriff (PDF)

Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus

Leukemia, 2007, Vol.21 (1), p.12-17

2007

Volltextzugriff (PDF)

Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group

Haematologica (Roma), 2007-01, Vol.92 (1), p.95-100

2007

Volltextzugriff (PDF)

Individual Patient Data–Based Meta-Analysis of Patients Aged 16 to 60 Years With Core Binding Factor Acute Myeloid Leukemia: A Survey of the German Acute Myeloid Leukemia Intergroup

Journal of clinical oncology, 2004-09, Vol.22 (18), p.3741-3750

2004

Volltextzugriff (PDF)

The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products

Bone marrow transplantation (Basingstoke), 2008-04, Vol.41 (8), p.687-705

2008

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party

Leukemia, 2016-10, Vol.30 (10), p.2047-2054

2016

Volltextzugriff (PDF)

Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT

Bone marrow transplantation (Basingstoke), 2021-03, Vol.56 (3), p.614-621

2021

Volltextzugriff (PDF)

Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time

Bone marrow transplantation (Basingstoke), 2005-11, Vol.36 (9), p.757-769

2005

Volltextzugriff (PDF)

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib

Leukemia, 2008-06, Vol.22 (6), p.1200-1206

2008

Volltextzugriff (PDF)

Latin America: the next region for haematopoietic transplant progress

Bone marrow transplantation (Basingstoke), 2017-05, Vol.52 (5), p.671-677

2017

Volltextzugriff (PDF)

1 – 25 von 676

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(610)
Mit Volltextzugriff
(568)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(407)
Science & Technology
(380)
Life Sciences & Biomedicine
(379)
Hematology
(257)
Biological And Medical Sciences
(239)
Female
(237)
Male
(232)
Medical Sciences
(225)
Adult
(224)
Middle Aged
(210)
Oncology
(165)
Transplantation
(151)
Aged
(125)
Medicin Och Hälsovetenskap
(125)
Adolescent
(124)
Immunology
(121)
Stem Cell Transplantation
(113)
Transplantation, Homologous
(108)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(102)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(102)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Bone Marrow Transplantation
(97)
Blood
(89)
Leukemia
(46)
Haematologica
(33)
Biology Of Blood And Marrow Transplantation
(29)
Journal Of Clinical Oncology
(27)
British Journal Of Haematology
(20)
Deutsche Medizinische Wochenschrift
(17)
Transplantation
(14)
Leukemia Research
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group

The challenge of biosimilars

Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation

Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT

The EBMT activity survey 2009: trends over the past 5 years

NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia

Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib

Alloreactivity: the Janus-face of hematopoietic stem cell transplantation

Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study

Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysis

Prediction of non-relapse mortality in recipients of reduced intensity conditioning allogeneic stem cell transplantation with AML in first complete remission

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009

Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT

Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus

Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group

Individual Patient Data–Based Meta-Analysis of Patients Aged 16 to 60 Years With Core Binding Factor Acute Myeloid Leukemia: A Survey of the German Acute Myeloid Leukemia Intergroup

Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT

The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products

Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party

Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT

Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib

Latin America: the next region for haematopoietic transplant progress

Suchergebnisse filtern